20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 3, 2009, Pages

  Dhanasekaran, Anuradha ^a   Bodiga, Sreedhar ^a   Gruenloh, Stephanie ^a   Gao, Ying ^a   Dunn, Laurel ^a   Falck, John R ^b   Buonaccorsi, J Noelle ^a   Medhora, Meetha ^a   Jacobs, Elizabeth R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Akt; Hypoxia; Phosphatidylinositol 3 kinase; Reactive oxygen species; Reduced nicotinamide adenine dinucleotide phosphatase oxidase

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BROXURIDINE; CASPASE 3; LIPOPOLYSACCHARIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; 20 HYDROXY 5,8,11,14 EICOSATETRAENOIC ACID; 20 HYDROXYEICOSA 5(Z),14(Z) DIENOIC ACID; 20-HYDROXY-5,8,11,14-EICOSATETRAENOIC ACID; 20-HYDROXYEICOSA-5(Z),14(Z)-DIENOIC ACID; ANDROSTANE DERIVATIVE; HYDROXYICOSATETRAENOIC ACID; PROTEIN KINASE INHIBITOR; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTERY ENDOTHELIUM; ARTICLE; CELL PROTECTION; CELL SURVIVAL; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; REOXYGENATION; ANIMAL; CATTLE; CELL CULTURE; CELL HYPOXIA; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; METABOLISM; MOUSE; PATHOLOGY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; APOPTOSIS; CASPASE 3; CATTLE; CELL HYPOXIA; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HYDROXYEICOSATETRAENOIC ACIDS; LIPOPOLYSACCHARIDES; MICE; NADPH OXIDASE; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; PULMONARY ARTERY; REACTIVE OXYGEN SPECIES;

EID: 64049113217     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01087.2008     Document Type: Article

References (38)

1. Abid MR, Kachra Z, Spokes KC, Aird WC. NAPDH oxidase activity is required for endothelial cell proliferation and migration. FEBS Lett 486: 252-256, 2000.
2. Amaral SL, Maier KG, Schippers DN, Roman RJ, Greene AS. CYP4A metabolites of arachidonic acid and VEGF are mediators of skeletal muscle angiogenesis. Am J Physiol Heart Circ Physiol 284: H1528- H1535, 2003.
3. Bain J, Plater R, Elliott M, Shapiro N, Hastie JP, McLauchlan H, Klevernic I, Arthur JSC, Alessi DR, Cohen P. The selectivity of protein kinase inhibitors: a further update. Biochem J 408: 297-315, 2007.
4. Brueckl C, Kaestle S, Kerem A, Habazettl H, Krombach F, Kuppe H, Kuebler WM. Hyperoxia-induced reactive oxygen species formation in pulmonary capillary endothelial cells in situ. Am J Respir Cell Mol Biol 34: 453-463, 2006.
5. Chen Y, Medhora MM, Falck JR, Pritchard KA, Jacobs ER. Mechanisms of activation of eNOS by 20-hydroxyeicosatetraenoic acid and VEGF in bovine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 291: L378-L385, 2006.
6. Chowdhury AK, Watkins T, Parinandi NL, Saatian B, Kleinberg ME, Usatyuk PV, Natarajan V. Src-mediated tyrosine phosphorylation of p47phox in hyperoxia-induced activation of NADPH oxidase and generation of reactive oxygen species in lung endothelial cells. J Biol Chem 280: 20700-20711, 2005.
7. Clerkina JS, Naughtona R, Quineya C, Cotter TG. Mechanisms of ROS modulated cell survival during carcinogenesis. Cancer Lett 266: 30-36, 2008.
8. Dhanasekaran A, Al-Saghir R, Lopez B, Zhu D, Gutterman DD, Jacobs ER, Medhora MM. Protective effects of epoxyeicosatrienoic acids (EETs) on human endothelial cells from the pulmonary and coronary vasculature. Am J Physiol Heart Circ Physiol 291: H517-H531, 2006.
9. Dunn KM, Renic M, Flasch AK, Harder DR, Falck JR, Roman RJ. Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 295: H2455-H2465, 2008.
10. Fernandes Bertocchi AP, Campanhole G, Wang PH, Goncalves GM, Damiao MJ, Cenedeze MA, Beraldo FC, de Paula Antunes Teixeira V, Dos Reis MA, Mazzali M, Pacheco-Silva A, Camara NO. A role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injury. Transpl Int 21: 999-1007, 2008.
11. Gebremedhin D, Lange AR, Lowry TF, Taheri MR, Birks EK, Hudetz AG, Narayanan J, Falck JR, Okamoto H, Roman RJ, Nithipatikom K, Campbell WB, Harder DR. Production of 20-HETE and its role in autoregulation of cerebral blood flow. Circ Res 87: 60 -65, 2000.
12. + channel currents in rat cerebral arterial muscle cells. Am J Physiol Heart Circ Physiol 294: H107-H120, 2008.
13. Griendling KK, Sorescu D, Ushio-Fukai M. NADPH oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
14. Guo AM, Arbab AS, Falck JR, Chen P, Edwards PA, Roman RJ, Scicli AG. Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation. J Pharmacol Exp Ther 321: 18-27, 2007.
15. Guo M, Roman RJ, Fenstermacher JD, Brown SL, Falck JR, Arbab AS, Edwards PA, Scicli AG. 9L gliosarcoma cell proliferation and tumor growth in rats are suppressed by N-hydroxy-N′-(4-butyl-2- methylphenol) formamidine (HET0016), a selective inhibitor of CYP4A. J Pharmacol Exp Ther 317: 97-108, 2006.
16. Gupta A, Sharma S, Nain CK, Sharma BK, Ganguly NK. Reactive oxygen species-mediated tissue injury in experimental ascending pyelonephritis. Kidney Int 49: 26-33, 1996.
17. Gutterman DD. Mitochondria and reactive oxygen species: an evolution in function. Circ Res 97: 302-304, 2005.
18. Imig JD, Zou AP, Stec DE, Harder DR, Falck JR, Roman RJ. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol Regul Integr Comp Physiol 270: R217-R227, 1996.
19. Ishizuka T, Cheng J, Singh H, Vitto MD, Manthati VL, Falck JR, Laniado-Schwartzman M. 20-Hydroxyeicosatetraenoic acid stimulates nuclear factor-kappaB activation and the production of inflammatory cytokines in human endothelial cells. Pharmacol Exp Ther 324: 103-110, 2008.
20. Kroetz DL, Xu F. Regulation and inhibition of arachidonic acid omega- hydroxylases and 20-HETE formation. Annu Rev Pharmacol Toxicol 45: 413-438, 2005.
21. Kroetz DL, Zeldin DC. Cytochrome P450 pathways of arachidonic acid metabolism. Curr Opin Lipidol 13: 273-283, 2002.
22. Kunert MP, Roman RJ, Onso-Galicia M, Falck JR, Lombard JH. Cytochrome P-450 omega-hydroxylase: a potential O(2) sensor in rat arterioles and skeletal muscle cells. Am J Physiol Heart Circ Physiol 280: H1840-H1845, 2001.
23. Medhora M, Daniels J, Mundey K, Fisslthaler B, Busse R, Jacobs ER, Harder DR. Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. Am J Physiol Heart Circ Physiol 284: H215-H224, 2003.
24. Medhora M, Chen Y, Gruenloh S, Harland D, Bodiga S, Zielonka J, Gebremedhin D, Gao Y, Falck JR, Anjaiah S, Jacobs ER. 20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 294: L902-L911, 2008.
25. Muthalif MM, Benter IF, Karzoun N, Fatima S, Harper J, Uddin MR, Malik KU. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodu-lin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci USA 95: 12701-12706, 1998.
26. Nilakantan V, Maenpaa C, Jia G, Roman RJ, Park F. 20-HETE-mediated cytotoxicity and apoptosis in ischemic kidney epithelial cells. Am J Physiol Renal Physiol 294: F562-F570, 2008.
27. Ray R, Shaw AM. NADPH oxidase and endothelial cell function. Clin Sci 109: 217-226, 2005.
28. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, Pagano PJ. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular and systolic blood pressure in mice. Circ Res 89: 408 - 414, 2001.
29. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 82: 131-185, 2002.
30. Tang PS, Mura M, Seth R, Liu M. Acute lung injury and cell death: how many ways can cells die? Am J Physiol Lung Cell Mol Physiol 294: L632-L641, 2008.
31. Ushio-Fukai M, Tang Y, Fukai T, Dikalov SI, Ma Y, Fujimoto M, Quinn MT, Pagano PJ, Johnson C, Alexander RW. Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ Res 91: 1160 -1167, 2002.
32. Wang JS, Singh H, Zhang F, Ishizuka T, Deng H, Kemp R, Wolin MS, Hintze TH, Abraham NG, Nasjletti A, Laniado-Schwartzman M. Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus. Circ Res 98: 962-969, 2006.
33. Wang MH, Zhang F, Marji J, Zand BA, Nasjletti A, Laniado-Schwartzman M. CYP4A antisense oligonucleotide reduces mesenteric vascular reactivity and blood pressure in SHR. Am J Physiol Regul Integr Comp Physiol 280: R255-R261, 2001.
34. Wang Z, Tang X, Li Y, Leu C, Guo L, Zheng X, Zhu D. 20-Hydroxyeicosatetraenoic acid inhibits the apoptotic responses in pulmonary artery smooth muscle cells. Eur J Pharmacol 588: 9 -17, 2008.
35. Williams JM, Sarkis A, Lopez B, Ryan RP, Flasch AK, Roman RJ. Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosa- tetraenoic acid contribute to pressure natriuresis. Hypertension 49: 687-694, 2007.
36. Yasuda M, Ohzeki Y, Shimizu S, Naito S, Ohtsuru A, Yamamoto T, Kuroiwa Y. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci 64: 249 -258, 1999.
37. Zhang Q, Chatterjee S, Wei Z, Liu WD, Fisher AB. Rac and PI3 kinase mediate endothelial cell-reactive oxygen species generation during nor- moxic lung ischemia. Antioxid Redox Signal 10: 679 -689, 2008.
38. Zhu D, Zhang C, Medhora M, Jacobs ER. CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium. J Appl Physiol 93: 330-337, 2002.